Hanclo Cream is a topical formulation combining Clobetasol propionate (0.05% w/w), Miconazole nitrate (2% w/w), and Neomycin sulfate (0.2% w/w), designed for the effective management of inflammatory dermatoses complicated by fungal and bacterial infections. Clobetasol, a potent corticosteroid, exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects, thereby reducing redness, swelling, and itching associated with various skin conditions. Miconazole, an imidazole antifungal agent, inhibits ergosterol synthesis in fungal cell membranes, providing broad-spectrum activity against dermatophytes, yeasts, and other fungi. Neomycin, an aminoglycoside antibiotic, targets susceptible gram-positive and gram-negative bacteria by inhibiting protein synthesis, thereby preventing or treating secondary bacterial infections. The synergistic combination in Hanclo Cream is particularly beneficial in conditions such as eczema, psoriasis, and dermatitis when complicated by mixed infections. It should be applied topically as directed by a healthcare professional, avoiding prolonged use to minimize potential adverse effects such as skin atrophy, irritation, or systemic absorption. Caution is advised in patients with known hypersensitivity to any component. Hanclo Cream is intended for external use only and should not be applied to open wounds or mucous membranes. Proper adherence to prescribed usage ensures optimal therapeutic outcomes.